mTORMechanistic target of rapamycin

mTOR, the mechanistic target of rapamycin, is a protein complex that acts as the cell's growth switch. When nutrients, particularly amino acids and especially leucine, are available and a growth signal such as mechanical loading or insulin arrives, mTOR activates and the cell starts building.

In muscle, that is the pathway resistance training and protein intake both converge on. It is the reason a hard set and a protein meal have a larger combined effect than either alone, and the mechanism behind the leucine threshold discussed on our protein pages.

It also switches things off. Activating mTOR suppresses autophagy, the cellular recycling process, which is where the tension in longevity research comes from: growth and cellular housekeeping are, to a degree, competing states.

That tension has produced an entire online argument about whether protein is good for muscle and bad for longevity. The animal data on mTOR inhibition and lifespan are real, rapamycin extends lifespan in mice reproducibly, and the leap to telling humans to eat less protein is not supported, particularly given that low protein intake and low muscle mass predict poor outcomes in older people.

Rapamycin itself is an immunosuppressant with meaningful side effects and no lifespan or healthspan trial in healthy humans. It is a genuinely interesting research compound and not a supplement.

Nothing sold as an mTOR booster or blocker in a bottle has evidence for changing human outcomes in either direction.

In practice, the useful reading is unglamorous: train, eat enough protein, and treat the growth versus longevity trade-off as an open research question rather than a reason to under-eat protein in later life.